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Thank you, Dr Crawford, for your very kind and overly generous intro-duction. People who know me well recognize the exaggerations, but forthe rest of you, please take everything he said as the gospel truth.I am standing here as president of The American Association forThoracic Surgery thanks to a lot of good fortune and, even moreimportant, thanks to some very good people. As I remarked when I
was leaving Johns Hopkins for Philadelphia, what I had become professionally at
that time was about one third the result of my own efforts and two thirds a result of
the Hopkins environment and my colleagues there. Whatever we have accomplished
at the University of Pennsylvania has been the result of teamwork, and the team has
included my superb colleagues in cardiothoracic surgery and anesthesia, a great
teaching environment, and some staunch supporters. Casey Stengel said, “Managing
a baseball team is getting paid for home runs someone else hits.” That has certainly
been my story at Penn. I am very grateful to the numerous people over the years who
have nurtured and supported my efforts and especially to my current colleagues in
Philadelphia. Very special thanks also go to my wife, Nina; to our 4 children, Julie,
Joby, Emily, and Nick; and to my close friends for the love, support, and happiness
that I have received from each of them.
Two years ago, in his excellent presidential address to this Association entitled
“The Innovation Imperative,” Toby Cosgrove began by stating: “For thoracic
surgeons, this is the best of times and the worst of times.” That was May 2000, when
the United States was at the prosperous apex of a peaceful and benign international
society, where goodwill and mutual respect reigned. We were in the midst of an
unprecedented and sustained economic boom that, as Toby pointed out, was pow-
ering the entrepreneurial dreams of millions of people. At that same AATS meeting,
we heard predictions of the anticipated effect of genetically based medicine by Craig
Venter, a visionary scientist who had forced the pace of development of the human
genome project by bold personal leadership and by gaining support for the project
from the private sector.
Now, just 2 years later, Americans have been shaken by the horror of September
11. We have had to confront a profound hatred and accept that our society, of which
we have been so confident, is not seen as benevolent and generous by many people
for whom we feel no malice. Even before that searing day in September, the
entrepreneurial glow had faded, and the bubble, although perhaps not burst, had, at
least, become a lot smaller. Even the human genome project has been forced to
confront the harsh demands that are encountered when a vision moves into the
implementation stage.
Back in May 2000, what were the factors that Toby said were responsible for the
worst-of-times circumstances? He cited the serious erosion of reimbursement for
surgical services; increasing competition from other medical specialists, in partic-
ular from interventional cardiologists; escalating malpractice actions; and a loss of
societal respect and esteem for the medical profession on the basis of a barely
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concealed suspicion that high-tech medical and surgical
care are, in some way, being driven by a crass profit motive.
Another commonly cited sign of our worst-of-times sce-
nario was the pervasive belief in our medical schools, and in
surgical residency programs, that thoracic surgery might no
longer be attracting the best and brightest young physicians.
Perhaps the worst symptoms of our professional melancholy
at that time were the disheartening examples of thoracic
surgeons telling their children and other young people with
an interest in thoracic surgery that ours is a career to avoid.
Has our situation improved during these past 2 years
while many aspects of the best-of-times scenario deterio-
rated? Have any of the negative factors of May 2000 been
ameliorated over the last 2 years? Most of us would answer
with a resounding “no” and would state that thoracic sur-
gery’s situation appears to have deteriorated further. In fact,
what now might be even more demoralizing than advice
from older surgeons to young people to stay out of the
specialty is the difficulty thoracic surgery residents are
having in finding appropriate career positions when finish-
ing their training. After spending a decade of postgraduate
training, including, in many instances, highly productive
periods of research and/or extra training in areas such as
congenital heart surgery, transplantation, and advanced vas-
cular surgery, thoracic surgery residents often struggle just
to find employment in professional environments for which
they are overtrained.
Thoracic surgery residents are frustrated and angry. They
see formerly attractive faculty positions at academic centers
disappearing as the practice of cardiac surgery shifts to the
community. They see older thoracic surgeons remaining
surgically active for more years than had been the case even
a decade ago. They look to us in national and regional
thoracic surgery associations and to the Board of Thoracic
Surgery, the Residency Review Commission, and the Tho-
racic Surgery Directors Association and wonder why we
have been unable—or in their view unwilling—to make
things right as they start up career ladders, access to which
is blocked or limited for many of them.
Other negative influences continue to affect the specialty
as well. Support for thoracic surgery services has declined
further, especially for cardiac surgeons. Our specialty’s
efforts to enlighten members of congress about the threat to
specialty care for Medicare patients might have staved off
some early, draconian reimbursement reductions, but we
have been distinctly unsuccessful to date in influencing in
any substantive way health policy specialists and legislators
by our direct political action.
Another ominous trend has been declining support for
surgeon-researchers by the National Institutes of Health
(NIH). In fact, the Center for Scientific Review (CSR), the
NIH agency that runs the peer review process for research
grant applications, proposed eliminating the 2 study sec-
tions that review most cardiothoracic and vascular grant
applications. A current proposal would send these applica-
tions to study sections and review groups comprised pri-
marily of basic scientists and medical specialists. In justi-
fication, CSR cites declining application submissions from
surgeons, as well as fewer thoracic surgeon–researchers to
serve as peer reviewers. This might be a chicken versus egg
argument, but wherever the true explanation lies, NIH-
funded research for many cardiothoracic surgeons could be
entering a death spiral, especially if the CSR is successful in
eliminating surgery-oriented study sections.
Another challenge for the specialty might be a result of
thoracic surgery’s success on the business side of medicine.
Consultants are still assuring their community-hospital cli-
ents, including those who are part of the new wave of
for-profit hospital ownership companies, that any hospital
with a cardiologist or 2 who can perform coronary catheter-
izations will become very profitable if a cardiac surgery
program is established. After a brief hiatus in new surgical
program starts in the United States, 2001 witnessed an 11%
increase in new open-heart programs nationally. Few states
have been able to withstand the pressure to dismantle Cer-
tificate of Need regulations that were established to ensure
the appropriateness of and need for new cardiac catheter-
ization laboratories and surgical programs.
A predictable result of the dispersion of open-heart sur-
gery programs has been the leakage of surgery activity from
academic centers, which still bear the responsibility for
resident training. Marginally adequate surgery training ex-
periences are commonplace, especially in key areas, such as
neonatal congenital heart surgery, esophageal surgery, off-
pump coronary artery bypass grafting, and limited-exposure
procedures in adult cardiac surgery. Another business fact
of life affecting our specialty is cardiothoracic surgery’s
role as a major profit center for hospitals; highly successful
and lucrative surgery programs are essential for many hos-
pitals’ financial viability, including academic medical cen-
ters. Hospital CEOs want star performers on their surgical
teams, surgeons who sometimes are marketed like marquee
idols in the hard-hitting competitive hospital and cardiovas-
cular program environment. Although there is nothing
wrong with publicly acknowledging our most accomplished
colleagues or even promoting our services and successes,
being forced to compete in a commercial environment can
make team-oriented initiatives difficult to achieve and might
devalue those programs that are so conıgured. This neces-
sary bottom-line orientation also might diminish surgery-
training priorities. Norman Shumway is quoted as saying:
“The only hard thing about cardiac surgery is getting to do
cardiac surgery.” This aphorism apparently resulted from
his experience as a trainee at the University of Minnesota
under C. Walton Lillehei at a time of such pioneering heart
procedures that surgery residents rarely got anywhere near
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the operating table. Some of our residents today find them-
selves at a similar disadvantage.
But does all of this professional angst really make this
the worst of times for thoracic surgery? Are we facing new
challenges that we have not seen before, or have these
demands been experienced previously but in different
guises? First off, let us acknowledge that some current
aspects of the specialty are fine. For the general thoracic
surgeon, this has been a generally favorable period. Chest
surgery has evolved over the past 40 years from being
dominated by difficult salvage procedures on patients with
tuberculosis and other inflammatory diseases to a highly
productive era of thoracic surgical oncology that continues
to advance today and will for the foreseeable future. Lung
transplantation and other novel surgical procedures for de-
generative pulmonary conditions, including congenital and
genetic diseases, have general thoracic surgeons expressing
positive sentiments about the future of this subspecialty. At
the recent General Thoracic Surgery Club meeting, referred
to by many of its members as their best professional meet-
ing of the year, they discussed new technologies available
for lung surgery, such as tissue sealants and cyber knife use.
They also discussed new approaches for lung cancer treat-
ment, including gene therapy, angiogenesis, and retinoids.
The field is on solid clinical footing, and trainees find plenty
of career opportunities in a variety of general thoracic
surgery settings of their choice. Sustained advances in tho-
racic oncology and in other areas, such as airway recon-
struction and surgical treatment of obstructive lung disease,
are expected. Minimally invasive videoscopic thoracic sur-
gery has been embraced and mastered, and the future seems
to be bright, indeed.
Even for the general thoracic surgeon, however, our
specialty is being seriously threatened. The worsening chal-
lenge of maintaining appropriate financial support for sur-
geons and for the effective but expensive services that we
provide is being experienced in similar ways throughout the
developed world, regardless of the nature of the various
national health care systems. Governments have assumed
the responsibility of ensuring, and in most instances insur-
ing, health care for its citizens. The United States claims to
have a free-enterprise medical system, but this is only
partially so. Clearly the overly regulated Medicare program
is the major force in health care coverage in this country.
Floyd Loop, in his presidential address to the AATS in
1998, commented that, “Washington is trying to establish
universal health care through regulations. . . . Congress
affects the legislative and regulatory requirements often
unwittingly, because the members are uninformed. The
legal profession [which dominates the legislative branch of
government] may strengthen society, but writing regula-
tions that affect science and medicine has not been one of
their distinguished contributions. Few members of any con-
gressional committee have enough background in technol-
ogy, medicine, or science to legislate in this area, nor are
they interested in acquiring such knowledge.” Those of us
who have attempted to engage members of congress or even
their staff and aides know how accurate Dr Loop’s obser-
vation is. When we attempt to inform the legislative pro-
cess, we are politely received, but the attention spans are
short, and levels of interest are minimal. Dr Loop predicted
in 1998 what has continued to unfold since then: “Once they
have squeezed physician reimbursement, the [government]
regulators will turn to suppressing medical advancements at
a time when we have an aging population.”
How can thoracic surgeons have an effect on our various
national health care programs? We must promote and nur-
ture health policy expertise within the specialty. Virtually
all active and respected participants of the health policy
community in North America and Europe are primary care
physicians. The Harvard Kennedy School Health Policy
course, conceived by Jack Matloff and supported by the
Thoracic Surgery Foundation for Research and Education,
has provided a good beginning for some of our colleagues.
Also, we must be willing to encourage and support those
few surgeons and other physicians familiar with the con-
temporary challenges of specialty medicine who choose
government service and especially those willing to assume
the burden of elective office. In Washington, as in most
national and regional governments, health policy, although
molded by policy gurus and managed by bureaucrats, is
transformed into action by elected or politically appointed
individuals. When a surgeon becomes a player in this latter
group in the US Federal Government, there can be some
rebalancing of this serious design flaw of our current legis-
lative and executive government model. Physicians, sur-
geons, scientists, and technology experts are not sufficiently
engaged in government activities. Again, to quote Dr
Loop’s presidential comments, “In a technologically based
society, this legislative climate of ignorance is inexcusable
and potentially fatal.” There is a thoracic surgeon in the US
Senate, but many of us are disappointed that Senator Frist
has not turned around Medicare physician reimbursement.
Many seem to consider him personally responsible for con-
tinued physician payment declines. The significance of his
participation in the US Senate, as with the participation and
leadership of the few other medical specialists in the House
of Representatives, in the executive agencies of govern-
ment, and at the NIH, Food and Drug Administration, and
Institute of Medicine, cannot be overemphasized. There is
another surgeon, Representative Greg Ganske from Iowa,
who is a Harvard-trained plastic surgeon, running this year
for the US Senate. We need to support these individuals,
even if the nuances of their political party or philosophy do
not correspond entirely or exactly with our own. Having
surgeons and other physicians who understand our profes-
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sional goals and challenges is decidedly more important, I
believe, than being in complete social or political concor-
dance with a physician-legislator.
As important as greater political and societal engagement
is for the future of the specialty, a much more fundamental
concern is causing widespread apprehension among us to-
day. Many believe that the golden era of thoracic surgery, or
at least that of cardiac surgery, has passed and that the future
of the specialty is limited and uncertain. Our clinical chal-
lenges have intensified, our support and rewards have di-
minished, our young colleagues are discouraged, and pro-
spective candidates for the specialty appear to be declining.
But again, let me pose the question: Are we facing new
challenges that we have not encountered previously, or are
we coping with challenges experienced before under differ-
ent guises? Let us look at some aspects of our specialty’s
history and see what insights into our present dilemmas we
might be able to achieve.
I personally was exposed, directly or tangentially, to a
few of the early and exciting developments in cardiac sur-
gery. My first mentor in medicine was Proctor Harvey, a
prote´ge´e of Paul Dudley White at Harvard, who was head of
cardiology at Georgetown here when Nina and I were
medical students. I assumed that I would be a cardiologist
until I saw Dr Charles Hufnagel in action—a true surgical
pioneer who, among other firsts in surgery, implanted a ball
valve in a patient’s descending aorta in the early 1950s to
treat severe aortic regurgitation. Dr Hufnagel’s long and
exciting days in the operating room, followed by real teach-
ing rounds until late in the evening, inspired me. Also, he
directed a research laboratory at Georgetown, where he
developed and studied a variety of mechanical prostheses
and techniques for valve replacement. I made a leap of faith
and applied for a surgery internship. After medical school,
Nina and I moved the short distance to Johns Hopkins for
our subsequent training. We arrived there the year after Dr
Blalock’s death. The hallway in the Department of Surgery
at Hopkins was lined, as is the case at many academic
centers, with pictures of the program’s former residents.
There had been a generation of thoracic surgeons at Johns
Hopkins who participated in the formative growth and early
accomplishments of cardiac surgery. Many of these same
Blalock-trained residents help lead this specialty, and this
Association, through the next decades of mind-boggling
expansion into the treatment of coronary artery disease,
aortic disease, transplantation, and neonatal surgery.
Vincent Gott, who had trained in surgery along with Dr
Shumway under Dr Lillehei and his associates at Minnesota
and then continued his own medical device research at the
University of Wisconsin and Hopkins, was my mentor and
surgical teacher at Hopkins, along with many other superb
surgeons and fellow residents. It was a somewhat unique
and idealistic environment, based solidly on a robust and
dedicated surgical tradition. David Skinner was a member
of the Hopkins Surgery Faculty at the same time when Mark
Orringer and I were residents together.
My training at Hopkins culminated with an all-too-brief
stint as registrar with Sir Brian Barratt-Boyes and his out-
standing team at Green Lane Hospital in Auckland. Sir
Brian is another master surgeon who, at that time, was
pushing back seemingly insurmountable obstacles and mak-
ing corrective infant heart surgery possible. As I watched a
truly brilliant surgeon for a relatively short time, I seemed to
be absorbing years of surgical training, experience, and a
mind set that has served me well.
I experienced another important influence in 1982, when
the cardiac surgery group at Hopkins was joined by Bruce
Reitz and Bill Baumgartner from Stanford. Some surgeons
speak of their thoracic surgery heritage in ways reminiscent
of how a philosopher or artist might be identified with a
particular school of thought or artistic style. We even have
some surgeons referring to themselves as second- or third-
generation DeBakey or Sabiston or Churchill or Kirklin
trainees. I feel like a Shumway trainee, once or twice
removed, on the basis of the tremendous influence that
Bruce Reitz had on my own practice of cardiac surgery. I
hope that we returned the favor to Dr Shumway through one
of our own favorite surgery residents.
Thoracic surgeons have been accused of practicing elder
worship, and if one reviews the presidential addresses to this
Association, you can find ample evidence of this propensity.
But we should look at our thoracic surgery heritage to
redefine our goals and to invigorate our spirits in what
remains a very demanding but innovative surgical specialty,
where the sky continues to be the limit in multiple dimen-
sions. Robert Wallace, in his presidential address to this
Association in 1995, told the story of having met a very
senior surgeon on his first day as a surgery intern. The
surgeon offered his sympathy, assuring Bob that surgery
had had its day and that he was embarking on a dead-end
career. Many of us are saying the same thing to our students,
residents, and young associates today, making the same
depressing and misguided error that Bob’s senior surgeon
made. We must focus on our heritage, its lessons, and its
inspirations and see what that history teaches us, not just
about the here and now but also about our future.
Who could possibly have imagined what would happen
in less than 50 years after Dr Blalock treated that first blue
child with a simple but at that time extremely challenging
operation? Not only was the operation itself an amazing
accomplishment, but the manner in which that particular
operation evolved should be a lesson for us. Dr Blalock was
a surgeon-researcher at Vanderbilt before being appointed
Surgeon-in-Chief at Hopkins. While at Vanderbilt, he at-
tempted to create an animal model of pulmonary hyperten-
sion by constructing subclavian-to-pulmonary artery con-
Presidential Address Gardner
652 The Journal of Thoracic and Cardiovascular Surgery ● October 2002
nections. With that experience, he was serendipitously
prepared to respond to Helen Taussig’s distress when she
lamented the underlying physiologic problem of inadequate
pulmonary blood flow in children with tetralogy of Fallot. It
is unlikely that a subclavian–pulmonary artery connection
would have been tried, let alone been imagined, without his
experience in the Vanderbilt research laboratory. Nor would
it have happened without his collaborative relationship with
Dr Taussig in an environment such as exists at Johns Hop-
kins.
A few years later, at a time when many very smart and
wise physicians were absolutely certain that a heart-lung
bypass machine would never function or function safely, Dr
Lillehei forged ahead with a technique for repairing the
heart that would never pass institutional review board mus-
ter today—parental cross-circulation. When crude but func-
tional cardiopulmonary bypass pumps became barely oper-
ational, a group of brave surgeons operating on desperate
but hopeful patients forced the medical community to ac-
knowledge the promise of cardiothoracic surgery.
The entire history of thoracic surgery is characterized by
such vision and by a determined willingness to take risks
with the expectation of progress. This is not a specialty that
has achieved what has been experienced over the last 60
years in cardiac surgery and over the last 80 years in chest
surgery by accepting the therapeutic status quo. We hear
thoracic surgeons speak of our specialty as being mature. If
mature in this context is meant to indicate established or
experienced, all right. But if mature is intended to connote
fulfillment, a flattening out or a loss of momentum and
progress, then these individuals are very wrong. They might
have reached their own peaks and their own personal bests,
but I am certain that the specialty is nowhere near achieving
and fulfilling its ultimate potential for the benefit of patients
with thoracic and cardiac disease.
How can I say that the future of our specialty is favor-
able, let alone bright and positive, at a time of apparent
declining cardiothoracic surgery activity, along with the
palpable demoralization and generalized ennui of so many
thoracic surgeons? How can we justify encouraging stu-
dents and residents to enter this specialty? And even more
germane to present circumstances, how can we defend hav-
ing our trainees or young faculty work in basic science
laboratories or pursue PhDs or spend time at places like
Harvard’s Kennedy School of Government or submit re-
search applications to the Agency for Health Quality Re-
search? I believe passionately in 2 basic principles of human
enterprise that have been firmly established by repeated
lessons of our history: progress is inevitable, and challenges
are overcome, either creatively or by adaptation and evolu-
tion. I am not foolish enough to try to predict when progress
and what specific improvements will be achieved, but I am
confident enough in our collective heritage and experience
to know that we will prosper, that our specialty will con-
tinue to evolve, and that our potential for achieving unimag-
ined progress as thoracic surgeons is quite unlimited. Al-
dous Huxley said the following in an essay titled The Case
of Voluntary Ignorance: “(The fact) that men do not learn
very much from the lessons of history is the most important
of all the lessons that history has to teach.”
Eighty years ago, surgery of the lung and chest was
nearly impossible. Fifty years ago, direct surgery on and in
the heart was a pipe dream. Those surgeons who pushed
thoracic surgery into reality, some of whom are here with us
today, were considered fools or even charlatans for promot-
ing high-risk surgery for patients with miserable and essen-
tially untreatable conditions, such as tuberculosis, lung can-
cer, congenital heart disease, rheumatic fever, esophageal
obstruction, and ischemic heart disease. The incredible
progress that has characterized the specialty over this period
has been the result of individual medical leadership, bold-
ness, risk taking, imagination, basic and translational re-
search, sustained hard work and dedication, and a very
special and unique mentoring environment within the spe-
cialty.
With this heritage and culture, why should we fear the
future? Are we and those coming behind us any less talented
or committed than those surgeons of 20 or 40 or 60 years
ago? Are the scientific, societal, ethical, and even financial
challenges of today orders of magnitude worse than these
same factors were 50 years ago? In fact, an accurate histor-
ical analysis of the earlier days of thoracic surgery will
dispel this commonly held opinion. In certain respects, our
challenges to continued exponential progress in thoracic
surgery today and in the immediate future pale in compar-
ison with those of 50, 40, or even 30 years ago.
So just where are we now? Is this really the worst of
times? Well, for this meeting of the Association, compared
with the first AATS meeting that I attended 30 years ago in
Atlanta, we received nearly 700 abstract submissions, the
greatest number ever and a 30% increase over 3 years. At
this meeting, compared with Atlanta 30 years ago, we have
nearly quadrupled the number of presentations. Attendance
continues to grow. The first clinical experience with a
totally implantable biventricular artificial heart has just been
presented, as was a maturing and promising experience with
beating heart coronary surgery. Forum presentations and
Lillehei resident presentations, many reporting on sophisti-
cated basic science studies, continue to be numerous and of
excellent quality. Over 35% of the presentations at this
meeting are from outside North America, giving ample
testament not just to the international breadth of our spe-
cialty’s strengths but also to the global collaborative nature
of thoracic surgery. We now have at least 3 major interna-
tional thoracic surgery meetings annually, including the
European Association for Cardio-thoracic Surgery, and we
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have developed a truly international thoracic surgery society
with CTSNet, the Cardiothoracic Surgery electronic com-
munity of over 18,000 thoracic surgeons.
What must we do to ensure our specialty’s future?
Clearly our core mission is the accomplishment of excellent
surgical care. Our residency programs must insure the best
possible training experiences and the best possible mentor-
ing. Marginal training experiences must be eliminated, and
inadequately prepared or inept individuals cannot be al-
lowed to practice as certified thoracic surgeons. Our ability
to monitor our clinical effectiveness and promote quality
improvement are unsurpassed today with instruments like
the Society for Thoracic Surgeons database programs, and
we must insist on compliance with contemporary quality-
assurance measures. If we are unable to provide high-
quality surgical care to our patients, we are worthless to
society.
We must also be driven by a compulsion for progress and
innovation. The fundamental and defining research tradition
that has resulted in so much progress in this specialty must
be vigorously supported, with the scope of the research and
development encompassing not just basic biologic research
but also fields including informatics and communications,
process improvement, outcomes analysis, education, and
competency assessment. In the traditional research areas,
we should continue to promote and invest heavily in trans-
lational research, an area in which we are uniquely quali-
fied. Dr Elias Zerhouni, the recently nominated director of
the NIH, predicted that this will be the biomedical century,
following what others at NIH referred to as the molecular
era. These research pursuits are not mutually exclusive, as
many in the basic science community fear. We can hope that
surgery, bioengineering, and imaging research will experi-
ence a renaissance of attention and support with Dr Zer-
houni’s broader view of the NIH’s mission.
Please do not misinterpret my message as ravings or the
wishful thinking of someone still sporting a suntan from our
golden era. I am absolutely certain that those coming along
behind this mature generation of thoracic surgeons will
surpass our accomplishments. One commonly claimed in-
dicator of the impending decline of US thoracic surgery is
the emergence of the “foreign medical graduate” in thoracic
residency programs, coincident with the alleged fleeing of
the best and brightest from training slots in our specialty.
Although some residents and trainees educated abroad do
struggle with cultural assimilation as they attempt and are
expected to function flawlessly in our demanding programs,
the future accomplishments of medicine, science, and tech-
nology in the United States will be greatly determined by
the work and productivity of first- and second-generation
new Americans. This country is a nation of immigrants—
the United States is what we have become today because of
the waves of newcomers, eager for opportunities for per-
sonal and societal improvement. Just as this current Amer-
ican generation has prospered from the participation and
influence of descendants of immigrants from central and
Eastern Europe, this next generation of Americans will be
enriched by Hispanic Americans and by the many brilliant
and hard-working young Asian Americans who we are most
fortunate to have within our ranks.
The American Association of Thoracic Surgery is our
direct link to the awesome heritage of this specialty of
thoracic surgery. For years, its members were practitioners
of lung and chest wall surgery only. Just as we have evolved
over the past 50 years to encompass cardiac, esophageal,
neonatal, and airway surgery, the Association will confront
our emerging challenges and help lead our specialty as it
evolves in ways that we can only speculate about at this
point. Our past president, Jim Cox, last year challenged us
to turn some of our attention to those parts of the world
where the benefits of thoracic surgery are yet to be experi-
enced. Our next president, Fred Crawford, is personally
committed to ensuring that thoracic surgery education and
training evolve most appropriately in a rapidly changing
environment. At the most recent Association Council meet-
ing, we established a Research Advisory Committee to be
led by Pedro del Nido, Alec Patterson, Craig Miller, and
other accomplished surgeon-researchers, whose charge it is
to keep the Association and the specialty focused on our
essential research and development mission. We enthusias-
tically embrace and support CTSNet’s vision for a global
cardiothoracic community, and we will continue to work
collaboratively with the Society of Thoracic Surgeons, with
our other regional professional societies, and with the Eu-
ropean Association for Cardio-thoracic Surgery.
To our young colleagues, I would like to emphasize that
the future is yours for the taking. If there is not the precise
opportunity that you envisioned for yourself, make it hap-
pen at the next best place. The sine qua non for success is
unequivocal surgical competence, but how else you define
yourself professionally and personally is limitless. Be well
informed and be personally involved with the public and
with health policy activities. Support research and innova-
tion, either through direct participation or by supporting
your colleagues who do pursue research and development
activities. Also, in whatever your professional setting, men-
tor and educate those working with you and those following
you in the specialty.
I thank the Association for the great honor of serving as
president. There are many others more deserving of this
honor, but I am very grateful to have had the opportunity to
join the distinguished line of thoracic surgeons who have
made this Association a beacon of our aspirations and
expectations for the future of thoracic surgery on the basis
of the incredible accomplishments of those surgeons who
have preceded us. Thank you.
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